Personalised Medicine - where to achieve the biggest impact?

Thank you very much for your willingness to fill in this short survey of approximately 5 minutes!

The European Commission has indicated that the potential benefits of personalised medicine are vast and many promising inventions are made. However, these promising inventions are not always broadly implemented or taken over by other regions. We will therefore establish and support networks between regions in different European countries that are active within personalised medicine.

The goal of this survey is to determine the scope within the field of Personalised Medicine for our project. We aim to maximise our impact by choosing a scope that is associated with a high (economic and social) impact that benefits from a European wide network which aligns research and research funds. Please fill in this survey to help us determine the best scope for this new initiative.

What's in it for you? We greatly encourage collaboration with experts within Personalised Medicine within this initiative. Also, let us know if you want to be kept up to date on our progress. In short: contact us to keep in touch!

Lieke.gerris@pnoconsultants.com and Michelle.poirot@pnoconsultants.com

What type of organisation do you represent?
Vereist antwoord

What is your field of expertise?
Vereist antwoord

250 tekens resterend

What disease area within personalised medicine benefits most from a European network and structuring of research and research funds? Why?
Vereist antwoord

1500 tekens resterend

Optional: How would you rate the following disease areas as scope?

(low) 1
2
3
4
5 (high)
Ageing related
Blood
Cancer
Cardiovascular
Congenital disorders
Ear
Infection
Inflamatory & immune system
Mental Health
Metabolic (eg Diabetes)
Musculoskeletal
Neglected diseases
Neurodegenerative
Oral and Gastrointestinal
Rare diseases
Renal and urogenital
Reproductive & childbirth
Respiratory
Skin

What technology type within personalised medicine benefits most from a European network and structuring of research and research funds? Why?
Vereist antwoord

1500 tekens resterend

Optional: How would you rate the following technology types as scope?

low (1)
2
3
4
5 (high)
Diagnostics
Drug delivery
eHealth/mHealth/BigData
Epidemiology
Genetics
Instruments
Medical devices
Novel drug targets
Therapeutics (biologicals)
Therapeutics (cell therapies)
Therapuetics (small molecule)
Vaccines

What would be your final recommendation and why?
Vereist antwoord

1500 tekens resterend